MedTrace Logo

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

NCT01942070 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 262

Last updated 2018-07-09

No results posted yet for this study

Summary

The aim of the current study is to test the clinical performance of the everolimus-eluting BVS compared with that of the durable polymer everolimus-eluting stent (EES) in patients undergoing PCI in the setting of acute MI.

Conditions

Interventions

DEVICE

Bioresorbable vascular scaffold

DEVICE

Durable polymer everolimus-eluting metallic stent

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Robert A Byrne, MB PhD · Deutsches Herzzentrum Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-03-31
Completion
2019-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01942070 on ClinicalTrials.gov